Needle Free Drug Delivery Market Analysis & Trends – Product (Microneedles, Nanopatches, Electronically Assisted Transport, Intranasal), Technology  - Forecast to 2025

Needle Free Drug Delivery Market Analysis & Trends – Product (Microneedles, Nanopatches, Electronically Assisted Transport, Intranasal), Technology - Forecast to 2025

  • November 2016 •
  • 144 pages •
  • Report ID: 4312518
The Global Needle Free Drug Delivery Market is poised to grow at a CAGR of around 10.5% over the next decade to reach approximately $16.12 billion by 2025. Some of the prominent trends that the market is witnessing include rising cases of chronic diseases had boasted demand for drug delivery, growing bio-pharmaceuticals across the globe, recent technological developments of needle free drug delivery and growth opportunities/investment opportunities.

Based on product type, the market is categorized into nanopatches, electronically assisted transport, microneedles, iontophoresis and intranasal.

Depending on the technology, the market is segmented into oral drug delivery system, inhaler technology, laser-based needle-free injectors, jet injectors, novel needle free technologies, spring-based needle-free injectors, transdermal patch technology and other needle-free technologies.

By application, the market is further segregated into pain management, insulin delivery for diabetes, vaccine delivery, pediatric injections, obstructive sleep apnea and other applications. By other applications, the market is further classified into angina, hypertension and other medical conditions.

This industry report analyzes the global markets for Needle Free Diabetes Management across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Needle Free Diabetes Management Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments